MURPHY ANDREW J sold REGN
October 14, 2026 · Form 4 insider transaction
MURPHY ANDREW J sold 55 shares of Regeneron Pharmaceuticals, Inc. at $762.57 per share, a transaction worth $41.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
55
Price
$762.57
Total value
$41.9K
InsiderMURPHY ANDREW J
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 14, 2026
Filing dateOctober 15, 2026
Shares owned after51,729
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 7, 2026.